Haohai Life Sciences: Three-focal-point artificial crystalline lens products of its subsidiary obtained a medical device registration certificate.

Haohai Life Sciences announced that its holding subsidiary, Henan Saimei Vision Biotechnology Co., Ltd., recently received the "Medical Device Registration Certificate of the People's Republic of China" for the three-focus artificial intraocular lens product issued by the National Medical Products Administration. This product is suitable for the visual correction of adult cataract patients without crystalline lenses, and the registration certificate is valid from June 1, 2026 to May 31, 2031. The product uses exclusive patented technology to customize the height and light energy distribution of each level of diffraction ring, and adopts precise filtering technology to further enhance visual quality and light energy utilization.